Quinoline

Quinoline

SCHEMBL19995127

c1ccc2ncccc2c1.c1conn1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.63
▸ NPC1 O15118 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ CYP3A4 P08684 3/20 0.40
▸ KDM4E B2RXH2 4/20 0.39
▸ HTT P42858 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ CASP1 P29466 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ HSP90AA1 P07900 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ NR4A2 P43354 1/20 0.39
▸ HSP90AB1 P08238 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL27480269 1.00 ALDH1A1 (0.63) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL27891121 0.91 ALDH1A1 (0.52) ALDH1A1NPC1POLBRAB9ACYP3A4
SCHEMBL27753337 0.88 ALDH1A1 (0.43) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL27548983 0.85 ALDH1A1 (0.46) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoxaline SCHEMBL27493680 0.84 ALDH1A1 (0.38) ALDH1A1NPC1POLBRAB9AKDM4E
Phenazine SCHEMBL27734838 0.82 MAPT (0.50) ALDH1A1NPC1POLBRAB9AKDM4E
Naphthalene SCHEMBL27805984 0.82 CYP2A6 (0.40) ALDH1A1CYP2A6
Quinoline SCHEMBL27641019 0.82 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
SCHEMBL4882550 0.81 ALDH1A1 (0.39) ALDH1A1NPC1POLBRAB9ACYP3A4
Cinnoline SCHEMBL27939099 0.80 ALDH1A1 (0.36) ALDH1A1NPC1RAB9ACYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210361642-A1 WASP-PROTECTING SMALL MOLECULES, COMPOSITIONS, METHODS AND USES THEREOF IN THE TREATMENT OF INNATE AND ACQUIRED IMMUNE-RELATED DISORDERS OR CONDITIONS BAR ILAN UNIVERSITY (IL) 2021-11-25 — — US claimed
EP-3515435-A1 WASP-PROTECTING SMALL MOLECULES, COMPOSITIONS, METHODS AND USES THEREOF IN THE TREATMENT OF INNATE AND ACQUIRED IMMUNE-RELATED DISORDERS OR CONDITIONS Bar-Ilan University (IL) 2019-07-31 — — EP claimed
CN-108713025-A Slave single carrier for treating the heart patient's condition and other pathology expresses the composition and method of multiple biological activities polypeptide 英特拉克森公司 2018-10-26 — — CN claimed
WO-2018055627-A1 WASP-PROTECTING SMALL MOLECULES, COMPOSITIONS, METHODS AND USES THEREOF IN THE TREATMENT OF INNATE AND ACQUIRED IMMUNE-RELATED DISORDERS OR CONDITIONS BAR ILAN UNIVERSITY (IL) 2018-03-29 — — WO claimed
CN-106986926-A The mutain and its preparation method of tear lipocalin with the compatibility to people's C MET receptor tyrosine kinases 皮里斯股份公司 2017-07-28 — — CN claimed
CN-104994851-A PYRAZOLYL-BASED CARBOXAMIDES I AS CRAC CHANNEL INHIBITORS GRUENENTHAL CHEMIE 2015-10-21 — — CN claimed
CN-101883845-B Engineered dendritic cells and uses for the treatment of cancer INTREXON CORP 2015-06-10 — — CN claimed
CN-103534355-A Vectors conditionally expressing protein INTREXON CORP 2014-01-22 — — CN claimed
CN-101421225-B Aromatic amine derivative and organic electroluminescent element using same IDEMITSU KOSAN CO 2013-11-06 — — CN claimed
CN-102241719-A Glycopyrrolate compounds and synthesis method thereof UNIV DALIAN TECH 2011-11-16 — — CN claimed
CN-1678192-A Arthropodicidal anthranilamides DU PONT (US) 2005-10-05 — — CN claimed
CN-1556806-A Arthropodicidal anthranilamides �Ű˾ 2004-12-22 — — CN claimed
CN-1555364-A Insecticidal diamides �Ű˾ 2004-12-15 — — CN claimed
CN-1541063-A Method for controlling particular insects by applying anthranilamide compounds ��Ļ���Ű˾ 2004-10-27 — — CN claimed
CN-1530371-A Fructose spiro-compound with anti-cancer activity 北京大学 2004-09-22 — — CN claimed
CN-1426392-A Propenecarboxylic acid amidoxime derivatives, process for their preparation and pharmaceutical compositions containing them GENE RES LAB CO N (US) 2003-06-25 — — CN claimed
CN-1369573-A deposition apparatus and deposition method SEMICONDUCTOR ENERGY LAB (JP) 2002-09-18 — — CN claimed
CN-1003627-B solid pesticide composition 组合化学工业株式会社 1989-03-22 — — CN claimed
CN-87102972-A Treatment senile dementia oxadiazoles useful — 1987-11-18 — — CN claimed
CN-85108655-A SOLID FARM CHEMICAL COMPOUND — 1986-09-10 — — CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210361642-A1 WASP-PROTECTING SMALL MOLECULES, COMPOSITIONS, METHODS AND USES THEREOF IN THE TREATMENT OF INNATE AND ACQUIRED IMMUNE-RELATED DISORDERS OR CONDITIONS XIAP, BRWD1, ZAP70 ALDH1A1 4585/4885NPC1 2333/4885POLB 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback